Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Feb 3;16(2):e0245868. doi: 10.1371/journal.pone.0245868

Exploratory study on the psychological impact of COVID-19 on the general Brazilian population

Antonio P Serafim 1,2,*,#, Ricardo S S Durães 2,#, Cristiana C A Rocca 1,#, Priscila D Gonçalves 1, Fabiana Saffi 1, Alexandre Cappellozza 3, Mauro Paulino 4, Rodrigo Dumas-Diniz 4, Sofia Brissos 5, Rute Brites 6, Laura Alho 7, Francisco Lotufo-Neto 1
Editor: M Harvey Brenner8
PMCID: PMC7857630  PMID: 33534820

Abstract

The COVID-19 pandemic has become one of the main international concerns regarding its impact on mental health. The present study aims to investigate the prevalence of depression, anxiety, and stress symptoms, and behavioral aspects amidst the COVID-19 pandemic in a Brazilian population. An online survey was administered from May 22 to June 5, 2020 using a questionnaire comprising of sociodemographic information, the Depression, Anxiety, and Stress Scale (DASS-21), and the Coping Strategies Inventory. Participants comprised 3,000 people from Brazil’s 26 states and the Federal District, with an average age of 39.8 years, women (83%), married (50.6%), graduates (70.1%) and employees (46.7%). Some contracted the virus (6.4%) and had dead friends or relatives (22.7%). There was more consumption of drugs, tobacco, medication, and food (40.8%). Almost half of participants expressed symptoms of depression (46.4%), anxiety (39.7%), and stress (42.2%). These were higher in women, people without children, students, patients with chronic diseases, and people who had contact with others diagnosed with COVID-19. The existence of a group more vulnerable to situations with a high stress burden requires greater attention regarding mental health during and after the pandemic. That said, it should be emphasized that these findings are preliminary and portray a moment still being faced by many people amid the pandemic and quarantine measures. Therefore, we understand that the magnitude of the impacts on mental health will only be more specific with continuous studies after total relaxation of the quarantine.

Introduction

In a pandemic such as the COVID-19 outbreak, people tend to be more susceptible to physical, cognitive, behavioral, and emotional changes (which are not necessarily related to the clinical condition of the disease) [1]. The COVID-19 pandemic has become one of the main international concerns regarding its impact on mental health. Specific stressors related to the pandemic are affecting the general population, professionals working in direct patient care, and professionals who are not directly on the front line (configured as indirect trauma) [2, 3]. There is an increase on the demands relating to mental health, and moreover, there is the need to find ways to address the outbreak’s consequences. The growing information on contamination and lethality rates associated with the absence of effective treatment or means of prevention such as vaccines may corroborate with the increase in demands on mental health [3, 4].

To flatten the virus’s transmission curve and prevent a collapse in health systems, quarantines have been adopted as a public health measure in many places worldwide and often involve isolation and varying degrees of restrictions in people’s movement. However, this form of protection has necessitated changes in people’s lives such as in how schooling and work are conducted (e.g., homeschooling and home office, respectively) and also harms the economic sector due to the closing of most “non-essential” commercial stores [5, 6]. It has also necessitated changes in the habits of people, such as reducing social contact, adopting new standards of hygiene, and having flexibility regarding new forms of adaptation to the situation, since it requires a commitment to self-care and care in relation to others. At the same time, quarantines may also have an important impact on the mental health of the population, the extent of which, a priori, is unpredictable.

A study of cancer patients in isolation reported psychological problems such as anxiety, depression, sleep disorders, abstinence, regression, and hallucinations; it was also observed that children seemed to respond better to isolation [7]. Focusing on COVID-19, a study in China showed that more than half of 1,210 participants expressed some level of depression, anxiety, and stress [8].

In Lebanon, the imposition of quarantine measures was found to be related to Post Traumatic Stress Disorder (PTSD) symptoms during the second week of isolation, with symptoms worsening in the fourth week [9]. In more specific populations, such as university students in Spain, 2,530 students and workers of the University of Valladolid had moderate to extremely severe levels of symptoms of anxiety (21.3%), depression (34.2%), and stress (28.1%) [10].

As the COVID-19 crisis is permeated by more doubts than answers mainly in relation to effective treatments, its impact on mental health could be a continuous phenomenon, crossing the quarantine period, and thereby becoming a new clinical condition of the pandemic. Given the above, it is clear that the development of mental health care and psychosocial well-being programs is as necessary as physical health care. The Mental Health and Psychosocial Support for Staff (MHPSS) [11] have already highlighted the need for support and understanding programs as such programs will make coping more appropriate and safer for the population, which will certainly result in mitigating mental health problems.

As if the peculiar complexity of COVID-19 in Brazil, for example, territorial extension and great social inequality, was not enough, the pandemic emerged amid a political and scientific conflict, which notably divided federal management on one side and state and municipal management on the other regarding the understanding of quarantine as an indicated measure. This polarization puts in risk the actions to address the spread of COVID-19, which is mainly affecting people living in regions and houses that are in an increased vulnerability to contamination and dissemination.

During the survey (May 22-June 5, 2020), Brazil reached further than 820,000 confirmed cases and almost 40,000 deaths. According to Coronavirus Resource Center—Johns Hopkins University (https://coronavirus.jhu.edu/map.html), currently, five months after the first case of contagion registered (Jan 26) in the country, there are over 3,669,995 infected and almost 116,000 deaths for COVID-19. The first death was registered on March 12, 2020 (covid.saude.gov.br).

In light of all of this, this study aimed to verify the prevalence of symptoms of depression, anxiety, and stress, as well as the use of coping strategies and adaptation on behaviors amidst quarantine measures. This study also aimed to obtain general health data regarding COVID-19 in a Brazilian population. Our main hypothesis was that the pandemic situation of COVID-19 would be accompanied by the presence of symptoms of anxiety, depression, and stress, besides changes in the coping behavior of the general Brazilian population.

Methods

Participants and procedures

We developed an anonymous online questionnaire, using the Google Forms platform, which allowed us to reach people across the country. The research was disclosed on Facebook, Instagram, in the media sector of the Institute of Psychiatry of the Hospital das Clínicas at the University of São Paulo and of the Health Psychology program at the Methodist University of São Paulo. Cross-sectional data were collected between May 22 and June 5, 2020, covering the 26 Brazilian states and the Federal District to be filled by quarantined persons. The information on this study is posted for public access on “Plataforma Brasil” (https://plataformabrasil.saude.gov.br), which is the national and unified base of research records involving human beings linked to the National Health Council, an organ of the Ministry of Health.

This study used a quantitative cross-sectional design through non-probabilistic sampling using the “snowball” method. An online questionnaire was created via a Google Forms link; the link was also made available on social media to be filled out by people in quarantine. The inclusion criterion was being ≥18 years. Exclusion criteria included forms sent after June 5, 2020. Thus, a total of 3,031 anonymous participants answered the online survey and thirty-one was excluded once they were sent on after the June 5 deadline, and therefore, 3,000 participants with an average age of 39.8 (SD = 13.0) were included in this study and there was no missing data.

Measures

We applied an online questionnaire consisting of 108 questions organized as follows: Twenty-one issues addressed to sociodemographic data (age, sex, marital status, Children, educational level, Number of people living at the residence), information about the general health conditions of the participants, about the COVID-19 contagion, death of relatives or friends, and behavior in the face of the demands generated by the pandemic. These alternatives were related to quantity formats (for example, the number of children), yes or no answers, or list of categories, such as the symptoms of COVID-19, which could be checked. To assess psychological symptoms, the Depression, Anxiety, and Stress Scale (DASS-21) was used, which had been adapted and validated in the Portuguese language [12]. This instrument consists of 21 questions, divided into three subscales, which are scored on a 4-point Likert scale. Each subscale is composed of seven items, which assess symptoms related to depression, anxiety, and stress. The total score is obtained by adding the scores of the seven items for each of the three subscales and multiplied by two.

The DASS-21 provides three scores (one per subscale), with possible scores having a minimum of “0” and a maximum of “21”, expressing the levels normal, mild, moderate, severe, and extremely severe. Higher scores on each scale correspond to more negative affective states. According to the results of the DASS-21, we organized the sample into two groups: asymptomatic (normal level) and symptomatic (levels from mild to extremely severe). For the coping strategy data, we adapted the questions from the Coping Strategy Inventory [13] also to the online format, which assesses the efforts made by people in coping with stressful, chronic, or acute situations. It consists of 66 items that include thoughts and actions, and whose intensity is measured using a scale from 0 (not used) to 3 points (uses in large quantities).

The questionnaire was constructed in a way that did not allow closing the page without all the alternatives having been answered. Once it is an online survey and without the possibility of physical signature, all participants only accessed the online form after reading the Informed Consent and having accepted it by clicking on the button that configured the voluntary participation agreement in the survey.

Statistical analysis

Data were analyzed using the Statistical Package for the Social Sciences version 23 (SPSS 23.0) software. Categorical variables were represented by frequency and percentage (%). The anxiety, depression, and stress scores did not present a normal distribution when the Kolmogorov-Smirnov normality test was performed (p-value = 0.001), resulting in the execution of non-parametric tests for later analyses. The Mann-Whitney U, Kruskal-Wallis H tests were used for consolidated comparison between demographic variables and symptomatic and asymptomatic groups and inter- and intra-group analyses. The Chi-square test was used to verify differences in the proportionality of frequencies to the analyzed variables and the respondent groups’ (i.e., asymptomatic and symptomatic) depression, anxiety, and stress scores with a significance level of p <0.05. The p-value <0.05 was considered significant in this study for all statistical analysis. Spearman’s correlation was used to analyze the association between variables, with the magnitude of the coefficients interpreted as either weak (0.1–0.3), moderate (0.4–0.6), or strong (≥0.7), both for positive and negative significance (cf. Dancey & Reidy [14]).

Ethics procedures

All subjects gave their informed consent for inclusion before they participated in the study. This study was approved following the procedures of mental health research protocols for COVID-19 (SARS-COV-2) by the National Council of Ethics in Research (CONEP) of Brazil (CAAE: 30503920.5.0000.0008). As it was an online survey and without the possibility of a physical signature, the participants only had access to the form after reading and accepting the Free and Informed Consent Terms (ICF) that was available at the bottom of the online page.

Results

Table 1 shows the sociodemographic characteristics and behavioral aspects of the participants.

Table 1. Sociodemographic and behavioral characteristics during the quarantine (N = 3000).

Variable Categories description f (%) M (SD)
Age 39.8 (13)
Age group
18–20 years old 140 (4.7) 19.1 (0.8)
21–30 years old 680 (22.7) 25.1 (2.8)
31–40 years old 843 (28.1) 36 (2.8)
41–50 years old 674 (22.5) 45.1 (2.9)
51–60 years old 435 (14.5) 55.1 (2.8)
61–70 years old 197 (6.6) 64.3 (2.6)
≥71 (Until 82 years old) 31 (1.0) 73.6 (3)
Sex
Female 2493 (83)
Male 507 (17)
Status
Single 1156 (38.5)
Married 1517 (50.6)
Divorced 279 (9.3)
Widowed 48 (1.6)
Children
No children 1422 (47.4)
≤16 years old 846 (28.2)
>16 years old 732 (24.4)
Number of people living at the residence
1 or 2 1058 (35.3)
03–05 1836 (61.2)
≥6 106 (3.5)
Occupation
Employed 1402 (46.7)
Autonomous 851 (28.4)
Unemployed 278 (9.3)
Retired 174 (5.8)
Student 295 (9.8)
Educational level
Primary and Secondary 384 (12.9)
University graduate 2103 (70.1)
Postgraduate (Master or PhD) 330 (17.0)
Evaluation of current health status Normal/Very good 2844 (94.8)
Weak 753 (25.1)
Chronic disease Yes 778 (25.9)
Close contact with infected people (Covid-19) Yes 1055 (35.2)
Deaths of relatives or friends by Covid-19 Yes 682 (22.7)
Have done Covid-19 test Yes 192 (6.4)
Reason (symptoms)
Mild to Moderate 179 (93.3)
Severe–ICU* 13 (6.7)
Wears mask, regardless of the presence of symptoms Always 2310 (77.0)
Agrees with the quarantine Yes 2541 (84.7)
Time at home due to the pandemic 20-24hrs 2086 (69.5)
Slept more than normal From little to very much 1839 (61.3)
Used drugs, medication, tobacco, or food for feeling good From little to very much 1224 (40.8)

f = frequency, M = mean, SD = standard deviation.

*ICU = intensive care unit.

Most respondents were women (83%; see Table 1). Ages ranged from 18 to 82 years, with 31 to 40 years (28.1%) being the most frequent age group. The criteria used for dividing the participants into age groups was based on Brazilian study by Pinheiro et al. [15] which analyzed stress during the COVID-19 pandemic in a situation of social distance. Most participants were married (50.6%), had college education (70.1%), and had children over 16 years old (24.4%). Most lived in houses of three to five people (61.1%), and most were either employed (46.7%) or self-employed (38.4%). A majority were reported to be in good health conditions (94.8%) and 25.9% reported chronic illness.

As for COVID-19, 35.2% reported contact with someone infected, 22.7% had relatives or friends who died, 6.4% contracted the virus, and 69.5% of the participants remained at home for 20 to 24 hours. Regarding the use of a mask and hygiene measures, 77 and 86.8%, respectively, reported always following these procedures. Regarding coping strategies, 61.3% reported an increase in hours of sleep, 40.8% perceived an increased intake of food, alcohol, drugs, tobacco, and medication.

Table 2 shows the results of the DASS-21 scale according to the sample distribution in two groups: “asymptomatic” (people who did not refer symptoms indicative scores for anxiety, depression, and stress) and “symptomatic” group (people who referred indicative scores of symptoms for anxiety, depression, and stress).

Table 2. Frequency of symptomatic and asymptomatic for depression, anxiety, and stress (N = 3000).

Variable Level f (%) p-value Prevalence f (%)
Depression (DASS-21ǂ)
 Asymptomatic 1608 (53.6)
 Symptomatic 1392 (46.4)
Mild 453 (32.5) 0.230+ 18–30 137 (21.2)
Moderate 489 (35.1) 18–30 185 (36.0)
Severe/extremely 450 (32.1) 18–30 215 (50.4)
Anxiety (DASS-21ǂ)
 Asymptomatic 1809 (60.3)
 Symptomatic 1191 (39.7)
Mild 218 (18.3) 0.010+ 18–30 64 (31.7)
Moderate 493 (41.4) 18–30 180 (36.1)
Severe/extremely 480 (40.3) 18–30 217 (45.4)
Stress (DASS-21ǂ)
 Asymptomatic 1734 (57.8)
 Symptomatic 1266 (42.2)
Mild 401 (31.7) 0.290+ 31–40 127 (30.7)
Moderate 422 (33.3) 18–30 156 (37.4)
Severe/extremely 443 (35.0) 18–30 219 (51.9)

f = frequency.

+p-values from chi-squared test.

ǂDepression, anxiety, and stress scale.

Highest prevalence by age group.

Table 2 shows that 46.4% of the participants showed symptoms of depression, 39.7% anxiety, and 42.2% stress. Analyzing the proportionality differences in frequencies in the levels of depression, anxiety, and stress, only the moderate level of stress was significantly more prevalent (p <0.01, Chi-square). As for the distribution of symptoms according to age, participants between 18 and 30 years old showed higher frequencies regarding depression and anxiety with mild to extremely severe levels, and moderate to extremely severe concerning stress.

Tables 3, 4, and 5 show the analyses of the symptomatic and asymptomatic groups in relation to the variables gender, children, professional situation, presence of chronic disease, contact with people infected with COVID-19, and participants diagnosed with COVID-19.

Table 3. Comparison of symptomatic and asymptomatic groups for depression.

Variable Total sample (N = 3000) Asymptomatic Depression Symptomatic Depression p(4)
M (SD) Md 95% CI p(1) f (%) M p(2) f (%) M p(3)
Sex
 Female 10.39 (8.8) 8 10.0–10.7 0.000+ 1277 (42.6) 4.7 0.000+ 1216 (40.5) 16.0 0.025+ 0.000*
 Male 7.5 (8.5) 4 6.8–8.2 333 (11.1) 1.2 174 (6.0) 15.2
Children
 No children 11.6 (9.3) 10 11.1–12.1 0.000+ 630 (21.0) 5.4 0.000+ 792 (26.4) 16.5 0.016+ 0.000*
 ≤16 years old 9.2 (8.3) 6 8.6–9.8 485 (16.2) 4.7 361 (12.0) 15.2
 >16 years old 7.5 (7.7) 6 6.9–8.0 495 (16.5) 3.9 237 (8.0) 14.9
Occupation
 Employed 9.4 (8.5) 8 9.0–9.9 0.000+ 816 (27.2) 4.8 0.037+ 586 (19.5) 15.9 0.000+ 0.000*
 Autonomous 8.8 (8.1) 6 8.2–9.3 488 (16.0) 4.6 363 (12.1) 14.4
 Unemployed 12.8 (10.12) 10 11.6–14.0 99 (3.3) 4.1 179 (6.0) 17.5
 Retired 7.4 (7.5) 6 6.2–8.5 118 (3.9) 4.3 56 (1.9) 13.8
 Student 14.1 (10) 12 13.0–15.3 89 (3.0) 6.2 206 (6.9) 17.6
Chronic disease
 Yes 11.5 (9.4) 10 10.8–12.2 0.000+ 392 (13.1) 4.7 0.000+ 386 (12.9) 17.6 0.000+ 0.020*
 No 9.3 (8.6) 8 9.0–9.7 1218 (40.6) 1.8 1004 (33.5) 15.2
Close contact with infected people
 Yes 12.4 (9.9) 10 11.6–13.3 0.000+ 241 (8.0) 4.7 0.000+ 261 (8.8) 18.5 0.000+ 0.004*
 No 9.4 (8.5) 8 9.1–9.7 1369 (45.6) 1.9 1129 (37.6) 15.3
Diagnostic of Covid-19
 Yes 17.0 (11.9) 14 14.4–19.5 0.000+ 37 (1.2) 4.7 0.000+ 50 (1.7) 23.8 0.000+ 0.024*
 No 9.7 (8.6) 8 9.4–10.0 1573 (52.4) 2.0 1340 (44.7) 15.6

M = mean, Md = median, SD = standard deviation, f = frequency, CI = confidence interval.

+p(1), p(2), p(3) values from Mann-Whitney/Kruskall-Wallis.

*p(4) values from chi-squared test.

Table 4. Comparison of symptomatic and asymptomatic groups for anxiety.

Variable Total sample (N = 3000) Asymptomatic Anxiety Symptomatic Anxiety
M (SD) Md 95% CI p(1) f (%) M p(2) f (%) M p(3) p(4)
Sex
 Female 13.3 (8.6) 12 13.0–13.6 0.001+ 1445 (48.2) 8.3 0.420+ 1048 (34.9) 20.1 0.213+ 0.001*
 Male 9.7 (8.5) 8 8.9–10.4 368 (12.3) 6.1 139 (4.6) 19.3
Children
 No children 14.3 (9.1) 14 13.9–14.8 0.001+ 747 (24.9) 8.5 0.001+ 675 (22.5) 20.7 0.001+ 0.001*
 ≤16 years old 12.2 (8) 12 11.7–12.8 537 (17.9) 8.2 309 (10.3) 19.3
 >16 years old 10 (7.9) 8 9.5–10.6 529 (17.6) 6.7 203 (6.8) 18.6
Occupation
 Employed 13.3 (8.5) 12 11.9–12.7 0.001+ 877 (29.2) 7.8 0.292+ 525 (17.5) 19.8 0.001+ 0.001*
 Autonomous 11.7 (8) 10 11.2–12.3 563 (18.8) 8.1 288 (9.6) 18.9
 Unemployed 15.3 (9.6) 14 14.2–16.4 125 (4.2) 8.1 153 (5.1) 21.1
 Retired 9.9 (7.5) 8 8.7–11.0 127 (4.2) 7.0 47 (1.6) 17.5
 Student 16.5 (9.7) 16 15.4–17.6 121 (4.0) 8.5 174 (5.8) 22.1
Chronic disease
 Yes 14.2 (9.1) 14 13.5–14.8 0.001+ 400 (13.3) 8.1 0.492+ 378 (12.6) 20.5 0.142+ 0.001*
 No 12.2 (8.5) 12 11.8–12.5 1413 (47.1) 7.8 809 (27.0) 19.7
Close contact with infected people
 Yes 14.6 (9.4) 12 13.8–15.4 0.001+ 246 (8.2) 8.2 0.204+ 256 (8.5) 20.8 0.192+ 0.001*
 No 12.3 (8.5) 12 12.0–12.6 1567 (52.2) 7.8 931 (31.0) 19.8
Diagnostic of Covid-19
 Yes 16.2 (9.9) 14 14.0–18.3 0.001+ 31 (1.0) 7.4 0.756+ 56 (1.9) 21 0.401+ 0.001*
 No 12.6 (8.6) 12 12.3–12.9 1782 (59.4) 7.9 1131 (37.7) 19.9

M = mean, Md = median, SD = standard deviation, f = frequency, CI = confidence interval.

+p(1), p(2), p(3) values from Mann-Whitney/Kruskall-Wallis.

*p(4) values from chi-squared test.

Table 5. Comparison of symptomatic and asymptomatic groups for stress.

Variable Total sample (N = 3000) Asymptomatic Stress Symptomatic Stress p(4)
M (SD) Md 95% CI p(1) f (%) M p(2) f (%) M p(3)
Sex
 Female 14.7 (8.1) 14 14.4–15.0 0.001+ 1374 (45.8) 9.9 0.001+ 1119 (37.3) 20.6 0.904+ 0.001*
 Male 11.9 (7.7) 10 11.2–12.6 363 (12.1) 8.5 144 (4.8) 20.4
Children
 No children 16.4 (8.7) 14 15.9–16.8 0.001+ 708 (23.6) 10.6 0.001+ 714 (23.8) 22.0 0.001+ 0.001*
 ≤16 years old 13.2 (7) 12 12.7–13.7 504 (16.8) 9.5 342 (11.4) 18.7
 >16 years old 11.3 (6.7) 10 10.8–11.8 525 (17.5) 8.4 207 (6.9) 18.5
Occupation
 Employed 13.3 (7.6) 12 12.9–13.7 0.001+ 841 (28.0) 9.1 0.001+ 561 (18.7) 19.5 0.001+ 0.001*
 Autonomous 13.5 (7.3) 12 13.0–14.0 516 (17.2) 9.6 335 (11.2) 19.4
 Unemployed 18.1 (9.4) 16 17.0–19.2 133 (4.4) 11.2 145 (4.8) 24.3
 Retired 11 (5.7) 10 10.1–11.8 132 (4.4) 9.0 42 (1.4) 17.3
 Student 19.3 (8.8) 18 18.3–20.3 115 (3.8) 12.5 180 (6.0) 23.8
Chronic disease
 Yes 15.3 (8.6) 14 14.7–15.9 0.001+ 396 (13.2) 9.5 0.947+ 382 (12.7) 21.2 0.068+ 0.001*
 No 13.9 (7.8) 12 13.6–14.2 1341 (44.7) 9.7 881 (29.4) 20.3
Close contact with infected people
 Yes 15.2 (8.9) 14 14.5–16.0 0.020+ 257 (8.6) 9.6 0.756+ 245 (8.2) 21.1 0.495+ 0.001*
 No 14 (7.9) 12 13.7–14.3 1480 (49.3) 9.6 1018 (33.9) 20.4
Diagnostic of Covid-19
 Yes 17 (9.7) 14 15.0–19.1 0.008+ 38 (1.3) 10.0 0.634+ 49 (1.6) 22.5 0.210+ 0.005*
 No 14.2 (8) 12 13.9–14.4 1699 (56.6) 9.6 1214 (40.5) 20.5

M = mean, Md = median, SD = standard deviation, f = frequency, CI = confidence interval.

+p(1), p(2), p(3) values from Mann-Whitney/Kruskall-Wallis.

*p(4) values from chi-squared test.

As shown in Tables 3, 4, and 5, the levels of depressive, anxiety, and stress symptoms. Regarding to p-value for characteristics, it was for sex, children, occupation, and chronic disease 0.000 (depression) and 0.001 (anxiety and stress); close contact with infected people 0.000 (depression), 0.001 (anxiety), and 0.020 (stress); diagnostic of Covid 0.000 (depression), 0.001 (anxiety), and 0.008 (stress).

Concerning higher levels, it was similar group characteristic for both. For depression were higher in women (median 8; 95% CI 10.0–10.7), people without children (median 10; 95% CI 11.1–12.1), students (median 12; 95% CI 13.0–15.3), patients with chronic diseases (median 10; 95% CI 10.8–12.2), and people who had contact with others with COVID-19 (median 10; 95% CI 11.6–13.3) or properly diagnosed with the virus (median 14; 95% CI 14.4–19.5). Regarding to anxiety were higher in women (median 12; 95% CI 13.0–13.6), people without children (median 14; 95% CI 13.9–14.8), students (median 16; 95% CI 15.4–17.6), patients with chronic diseases (median 14; 95% CI 13.5–14.8), who had close contact with infected people (median 12; 95% CI 13.8–15.4) and participants diagnosed with the virus (median 14; 95% CI 14.0–18.3). Likewise, findings higher levels for stress were in women (median 14; 95% CI 14.4–15.0), people without children (median 14; 95% CI 15.9–16.8), students (median 18; 95% CI 18.3–20.3), patients with chronic diseases (median 14; 95% CI 14.7–15.9), and people who had contact with others with COVID-19 (median 14; 95% CI 14.5–16.0) and which were diagnosed with the virus (median 14; 95% CI 15.0–19.1). In the intragroup analyses, in relation to depression (Table 3), the prevalence of previous results is maintained (p2 = 0.001; p3 = 0.001).

Regarding anxiety (see Table 4) in the symptomatic group, only participants with or without children and different professional situations have significant differences, with couples without children and students presenting a higher level of anxiety symptoms (p3 = 0.001). For stress (see Table 5), there was no significant difference in stress levels in relation to gender (p3 = 0.904), presence of chronic disease (p3 = 0.068), occurrence of contact with people close to the virus (p3 = 0.495) or have a diagnosis of the disease (p3 = 0.210).

From the analysis of the frequency distribution between the asymptomatic and symptomatic groups, women, people without children, the unemployed, students, people with chronic diseases, and people who had contact with people who were diagnosed with the virus or who were diagnosed with COVID-19, expressed a higher proportion of depressive, anxious and stress symptoms in relation to their own classification within the set of variables (p4 in Tables 3, 4, and 5). Table 6 presents the results of the correlation between studied variables.

Table 6. Correlation of among sociodemographic variable, coping strategies, depression, anxiety, and stress (N = 3000).

Spearman’s Correlation Coefficient 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12.
1. Depression 0.607** 0.680** -0.301** 0.132** -0.095** 0.053** 0.048** 0.064** 0.091** 0.289** 0.352**
2. Anxiety 0.701** -0.265** 0.088** -0.121** 0.114** 0.108** 0.058** 0.041* 0.189** 0.301**
3. Stress -0.289** 0.089** -0.089** 0.092** 0.061** 0.049** 0.036* 0.218** 0.369**
4. Age -0.071** 0.178** 0.167** -0.010 -0.092** -0.045* -0.257** -0.225**
5. Occupation -0.191** 0.029 -0.011 -0.024 0.202** 0.103** 0.037*
6. Educational level 0.021 -0.036 0.073** 0.065** -0.070** -0.008
7. Chronic disease -0.012 -0.003 0.030 0.041* 0.025
8. Diagnosis Covid-19 -0.036* -0.076** 0.017 -0.015
9. Agrees with the quarantine 0.193** 0.067** 0.037*
10. Time at home 0.110** 0.024
11. Slept more than normal 0.246**
12. Drugs, medication, or ate for feeling good

*≤0.01.

**≤0.05.

Depression was shown to have a moderate positive result with anxiety and stress; weak positive with an occupation, sleeping more and using drugs, drugs or eating more to feel good; and moderate negative with age. Whereas anxiety was positive strong with stress; weak positive with chronic illness, COVID-19 diagnosis, sleeping more and using drugs, drugs or eating; weak negative with age and education level. Stress had a weak positive correlation with sleeping more and using some substance to feel better, and weak negative with age.

Discussion

This study aimed to examine the psychological impact of COVID-19 in an adult sample in Brazil and had the participation of people from all regions of the country. Verifying the pandemic’s impact on mental health may provide the needed information to promote policies to assist affected populations.

Our sample was characterized by more women and married people, ages ranged from 18 to 82 years, with those between 30 and 40 years having greater participation. Most had some college education, were working, and were in good health condition. A third of respondents disclosed that they had contact with people with COVID-19 and a small proportion contracted the virus. The few studies exploring the pandemic’s psychological impact had a similar prevalence of women [2, 8, 10, 16, 17], except for a study that investigated the psychological symptoms of ordinary Chinese citizens in the early stages of the pandemic, which had more men [18]. Women in many cultures assume overly broad responsibilities: besides their professional role, they often end up being at the heart of household chores and childcare [19]. Also, it must be noted that among women, there is a high prevalence of violence and abuse, which has been exhibited in other epidemics such as the Ebola and Zika virus outbreaks in 2013–2016 and 2015–2016, respectively. A field in which the majority of workers are predominantly women is that of health and social services, which necessitates the urgency to not only train women professionally but also to provide them with more resources when they assume primary responsibility for work domestic [19].

The sociodemographic variables observed in this study, such as the number of married people, educational level, and the number of residents in the house, are similar to those identified in a recent study in China [8]. However, for the participants in that study, the largest age group comprised those between 20 and 30 years and more than half were students.

Psychological impact

Regarding psychological impact, symptoms of depression, anxiety, and mild to moderate stress, were found in almost half of our sample, which was in accordance with the presence of symptoms experienced less than a week before the conducting of the survey [12]. According to the DASS’s foundation, the presence of depressive symptoms is associated with hopelessness, low self-esteem, and low incentive. So, as for anxiety is associated with physiological hyperstimulation and stress, which is an emotional state that varies according to an individual’s assessment of situations experienced as a threat, damage, or challenge, coupled with increased irritability and limitation of frustration [18]. The presence of depressive, anxious, and stress symptoms may at some point cause emotional changes or physiological changes in the hypothalamic-pituitary-adrenal (HPA) axis, for example, as highlighted in past studies [20].

In this sense, one must consider that biological models have shown that hypo- sensitivity or hypersensitivity may be markers of "trait" of individuals with affective disorders and temperament characteristics similar to those found in patients with mood disorders (affective temperament), have a higher probability of suffer from hopelessness and this is a predictive aspect for suicide risk [21, 22]. Thus, research that addresses behavioral signs related to anxiety, depression and mild to moderate stress associated with COVID-19 raise an important alarm for public health services, which need to be prepared for the increased demand and urgency in the treatment of new cases of mental disorders.

These findings corroborate the results of Wang et al. [8], who surveyed 210 Chinese people using the DASS-21 and IES-R (Impact of Event Scale-Revised) questionnaires. Their findings revealed severe levels of depressive symptoms (30.3%), anxiety (36.4%), and stress (32.1%). Our indexes were also of a serious level; however, they were higher on the DASS-21 scale compared to the study by Wang et al. [8]. The risks of the COVID-19 pandemic’s psychological impact on the mental health of the general population have been discussed in previous studies, although these have been mostly theoretical in the form of editorials, letters to the editor, and comments [3, 4, 2325].

Other studies exploring specific populations also show a psychological impact that corroborates our findings. A study assessing 460 Portuguese university students (with an average age of 20.14 years) using the DASS-21 observed high levels of anxiety, depression, and stress in this population [26]. In Spain, 2,530 students and workers of the University of Valladolid, presented moderate to extremely severe levels in terms of symptoms of anxiety (21.34%), depression (34.19%), and stress (28.14%) [10]. Another study, which evaluated psychopathological symptoms online through the Self-Report Symptom Inventory (SCL-90) in 1.600 participants, had more than 70% of participants expressing moderate to severe indices of anxiety, compulsions, and psychoticism [17]. Researchers in Lebanon using the Post-Traumatic Stress Disorder Checklist (PTSS) among 950 civilians, demonstrated that 33.2% of respondents had symptoms of PTSD.

As for depression, there was a higher prevalence in women than men in our study. Past studies have emphasized that depression is twice as prevalent in young women as in men, although it decreases throughout life and as triggers, women tend to have more internalizing symptoms [27]. Also, it is possible that regardless of age, professional status, marital status, education, and maternity, a condition such as a pandemic imposes an even greater burden on one’s duties during confinement, causing greater psychological distress. These aspects also extend to stress anxiety levels.

It is well known that the pandemic has an emotional burden relating to concerns about contamination rates, people who need treatment in intensive care units, risk of death, and vulnerable populations [11]. Therefore, it was expected that participants who had contact with people close to or diagnosed with COVID-19 would express high levels of symptoms of depression, anxiety, and stress, which corroborates the findings of other studies [2, 8, 9, 28, 29].

Although the majority of the population works, has a degree, and is married, our results suggest that these variables are not protective factors for mental health and that the pandemic does indeed have an impact and magnitude that is difficult to measure. In the case of students, they probably feel more threatened and insecure about the future, in addition to having their mobility and social contact being reduced. In this population segment, research in Spain and Portugal showed indications of the pandemic’s psychological impact [10, 26].

Despite the number of unemployed being less than 10% in our sample, there was an observed increase in psychological suffering. Although it was not verified whether unemployment resulted from the pandemic or not, the indicators of elevated symptoms of depression, anxiety, and stress corroborate previous findings on psychological processes and unemployment. Studies have highlighted that unemployed people were more likely to experience depressive symptoms, more stress, and less well-being compared to employed individuals [30, 31]. Also, unemployment is associated with an increased risk of mortality for those in the early and middle periods of their careers, compared to those at the end [32].

Behavioral coping strategies

Coping strategy behaviors can be either positive or negative [33]. A little less than half of our sample reported an increase in sleeping hours, food intake, alcohol use, drug use, tobacco use, and medication because of the pandemic. These behaviors denote the participants’ adoption of a negative escape-avoidance strategy, and such a strategy usually involves people imagining possible solutions to a problem without, however, taking actions to change them [33]. This finding corroborates with previous studies, since, in situations of high pressure and stress, people tend to adopt more negative strategies [34]. That said, the symptoms of stress may be associated with feelings of threat, harm, and challenge in the face of changes in behavior that the COVID-19 pandemic imposed on the population, aspects that have already been reported in past studies [35, 36].

The use of face masks and hand sanitizer was evidenced to not happen all the time, thus presenting a risk factor for contamination and the spread of the virus. This points out the need to develop programs that enable people to adopt healthy habits and behaviors, translated into concrete measures to reduce the contamination of COVID-19. In primary care, a method for prevention is through “counseling,” which represents the directed use of communication and problem-solving techniques capable of stimulating people to change behaviors and adopt safer and healthier lifestyle habits. According to Oliveira et al. [37], the relevance of counseling for the promotion, prevention, and control of diseases is such that it is no longer possible to provide complete and technically correct primary care programs without the inclusion of counseling for healthy habits and behaviors.

In the scope of psychological impact, research thus far, even if still quite small, is quite suggestive of the possible damage of the pandemic to mental health, emphasizing the need for public health policies that value​ encouraging not only physical care but also emotional care, with programs that can stimulate and teach techniques for handling emotions, to reduce anxiety and stress [38]. In addition, it is necessary to consider that the occurrence of depressive, anxious, and high-stress symptoms in adults, which can also result from trait markers [21, 22], raises the concern that directing attention to children and adolescents is fundamental.

Children and adolescents depend on the care of protective figures, who are fragile and end up failing to provide the necessary support and care, leaving them in a situation of vulnerability and, therefore, very susceptible to stressful experiences [39].

Study limitations

This study has limitations that must be considered when interpreting the results. As the sample composition was voluntary and online within a short period, we were unable to perform randomization, and so, for example, most participants were with a higher level of education, making the sample more selective. We also did not verify, in the cases of the unemployed, whether they lost their jobs during the pandemic. We also did not verify the presence of a previous history of mental disorders, which would certainly produce a clearer picture of the psychological impact in the face of the pandemic.

Conclusion

Despite these limitations, our findings showed the presence of important psychological changes in the general population. Women, people without children, the unemployed, students, people with chronic diseases, and participants who had contact with close people infected or diagnosed with the virus, were more susceptible to its psychological impact. This may suggest the existence of a group of greater vulnerability for situations with a high-stress load and which requires greater attention in terms of society’s proposals for its management. The fact that women and people without children, as well as unemployed people, present higher levels of psychological changes raises the hypothesis that the situation of the pandemic may put them in a condition of lack of perspective, as the uncertainty about the future and other uncertainties tend to cause uncomfortable sensations, anguish, and anxiety, in addition to the possible feeling of helplessness. Therefore, expanding psychiatric care services, training more qualified professionals in the management of psychological impacts in the face of the pandemic, within the scope of cognitive-behavioral therapy and psychoeducation, for example, will certainly reduce the mental health problems in this population.

That said, it should be emphasized that these findings are preliminary and portray a moment still being faced by many people amid the pandemic and quarantine measures. Therefore, we understand that the magnitude of the impacts on mental health will only be more specific with continuous studies after total relaxation of the quarantine.

Supporting information

S1 Data

(XLS)

Acknowledgments

We would like to thank all the people who were willing to answer this survey.

Data Availability

The data are fully available and were made available on the submission platform in the topic "Supporting information" with the file "Covid-19 Research Database General Population Brazil".

Funding Statement

This research received no external funding.

References

  • 1.Zhang J, Weili W, Zhao X, Zhang W. Recommended psychological crisis intervention response to the 2019 novel coronavirus pneumonia outbreak in China: A model of West China Hospital. Precis. Clin. Med. 2020; 3(1):3–8 10.1093/pcmedi/pbaa006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Li Z, Ge J, Yang M, Feng J, Qiao M, Jiang R, et al. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav. Immun. 2020; 88:916–919. 10.1016/j.bbi.2020.03.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Santos CF. Reflections about the impact of the SARS-COV-2/COVID-19 pandemic on mental health. Braz. J. Psychiatry. 2020; 42:329–332. 10.1590/1516-4446-2020-0981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Serafim AP. Gonçalves PD, Rocca CC, Lotufo Neto F. The impact of COVID-19 on Brazilian mental health through vicarious traumatization. Braz. J. Psychiatry. 42(4):450 10.1590/1516-4446-2020-0999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wilder-Smith A. Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J. Travel Med. 2020;27:taaa020. 10.1093/jtm/taaa020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Prem K. Liu Y. Russell TW, Kucharski AJ, Eggo RM, Davies N, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020; 5:e261–70. 10.1016/S2468-2667(20)30073-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kellerman J, Rigler D, Siegel SE. The psychological effects of isolation in protected environments. Am. J. Psychiatry. 1977; 134:563–565. 10.1176/ajp.134.5.563 [DOI] [PubMed] [Google Scholar]
  • 8.Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 Coronavirus Disease (COVID-19) epidemic among the general population in China. Int. J. Environ. Res. Public Health. 2020; 17:1729 10.3390/ijerph17051729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fawaz M, Samaha A. COVID-19 quarantine: Post-traumatic stress symptomatology among Lebanese citizens. Int. J. Soc. Psychiatry. 2020; 66(7):666–674. 10.1177/0020764020932207 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Odriozola-González P, Planchuelo-Gómez Á, Irurtia MJ, de Luis-García R. Psychological effects of the COVID-19 outbreak and lockdown among students and workers of a Spanish university. Psychiatry Res. 2020;290:113108 10.1016/j.psychres.2020.113108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mental Health and Psychosocial Support for Staff (MHPSS), Psychosocial Centre–International Federation of Red Cross and Red Crescent Societies, 2020. http://pscentre.org/wp-content/uploads/2020/02/MHPSS-in-nCoV-2020_ENG.pdf (accessed 29 June 2020).
  • 12.Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. J. Affect. Disord. 2014;155:104–109. 10.1016/j.jad.2013.10.031 [DOI] [PubMed] [Google Scholar]
  • 13.Savóia MG, Santana PR, Mejias NP. Adaptação do Inventário de Estratégias de Coping de Folkman e Lazarus para o português. Psicol. USP. 1996; 7:183–201. [Google Scholar]
  • 14.Dancey CP, Reidy J. Statistics without maths for psychology. 5th ed Harlow: Prentice Hall; 2011. [Google Scholar]
  • 15.Pinheiro GA, Luna GI, Santos RAC, Pimentel SFP, Varão AC. Perceived stress during a period of social distancing: differences between sexes. Braz. J. Hea. Rev. 2020; 3(4):10470–10486. 10.34119/bjhrv3n4-264 [DOI] [Google Scholar]
  • 16.Xiao H, Zhang Y, Kong D, Li S, Yang N. Social capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China. Med. Sci. Monit. 2020; 26:e923921 10.12659/MSM.923921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tian F, Li H, Tian S, Yang J, Shao J, Tian C. Psychological symptoms of ordinary Chinese citizens based on SCL-90 during the level I emergency response to COVID-19. Psychiatry Res. 2020; 288:112992 10.1016/j.psychres.2020.112992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Apóstolo JLA, Mendes AC, Azeredo ZA. Adaptation to Portuguese of the Depression, Anxiety and Stress Scales (DASS). Rev. Latino-Am. Enfermagem. 2006; 14:863–871. 10.1590/S0104-11692006000600006 [DOI] [PubMed] [Google Scholar]
  • 19.Peterman A, Potts A, O’Donnell M, Thompson K, Shah N, Oertelt-Prigione S, et al. Pandemics and violence against women and children [Internet]. Center for Global Development. 2020. https://www.cgdev.org/sites/default/files/pandemics-and-violence-against-women-and-girls.pdf (accessed July 2020).
  • 20.Mello AF, Juruena MF, Pariante CM, Tyrka AR, Price LH, Carpenter LL, et al. [Depression and stress: Is there an endophenotype?]. Braz. J. Psychiatry. 2007; 29 (Suppl 1):S13–8. 10.1590/s1516-44462007000500004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Serafini G, Pompili M, Innamorati M, Gentile G, Borro M, Lamis DA, et al. Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci. 2012; 16(10):1389–98. [PubMed] [Google Scholar]
  • 22.Engel-Yeger B, Muzio C, Rinosi G, Solano P, Geoffroy PA, Pompili M, Amore M, Serafini G. Extreme sensory processing patterns and their relation with clinical conditions among individuals with major affective disorders. Psychiatry Res. 2016;236:112–118. 10.1016/j.psychres.2015.12.022 [DOI] [PubMed] [Google Scholar]
  • 23.Galea S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing: The need for prevention and early intervention. JAMA Intern. Med. 2020;180:817–818. 10.1001/jamainternmed.2020.1562 [DOI] [PubMed] [Google Scholar]
  • 24.Montemurro N. The emotional impact of COVID-19: From medical staff to common people. Brain Behav. Immun. 2020; 30:S0889-1591(20)30411-6. 10.1016/j.bbi.2020.03.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Banerjee D. The COVID-19 outbreak: Crucial role the psychiatrists can play. Asian J. Psychiatr. 2020; 50, 102014 10.1016/j.ajp.2020.102014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Maia BR, Dias PC. Ansiedade, depressão e estresse em estudantes universitários: O impacto da COVID-19. Estud. Psicol. (Campinas). 2020; 37:e200067 10.1590/1982-0275202037e200067 [DOI] [Google Scholar]
  • 27.Albert PR. Why is depression more prevalent in women? J. Psychiatry Neurosci. 2015; 40:219–221. 10.1503/jpn.150205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw. Open. 2020; 3:e203976 10.1001/jamanetworkopen.2020.3976 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: Address mental health care to empower society. Lancet. 2020; 395:e37–e38. 10.1016/S0140-6736(20)30309-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim SS, Muntaner C, Kim H, Jeon CY, Perry MJ. Gain of employment and depressive symptoms among previously unemployed workers: A longitudinal cohort study in South Korea. Am. J. Ind. Med. 2013; 56:1245–50. 10.1002/ajim.22201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Oliffe JL, Han CS. Beyond workers’ compensation: Men’s mental health in and out of work. Am. J. Mens. Health 2014; 8:45–53. 10.1177/1557988313490786 [DOI] [PubMed] [Google Scholar]
  • 32.Parmar D, Stavropoulou C, Ioannidis JP. Health outcomes during the 2008 financial crisis in Europe: Systematic literature review. BMJ. 2016; 354:4588 10.1136/bmj.i4588 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Folkman S, Moskowitz JT. Positive affect and the other side of coping. Am. Psychol. 2000; 55:647–654. 10.1037//0003-066x.55.6.647 [DOI] [PubMed] [Google Scholar]
  • 34.Chan ST, Khong PCB, Wang W. Psychological responses, coping and supporting needs of healthcare professionals as second victims. Int. Nurs. Rev. 2017;64:242–262. 10.1111/inr.12317 [DOI] [PubMed] [Google Scholar]
  • 35.Smith JP, Randall CL. Anxiety and alcohol use disorders: Comorbidity and treatment considerations. Alcohol Res. 2012;34:414–31. [PMC free article] [PubMed] [Google Scholar]
  • 36.Razzoli M, Pearson C, Crow S, Bartolomucci A. Stress, overeating, and obesity: Insights from human studies and preclinical models. Neurosci. Biobehav. Rev. 2017; 76:154–162. 10.1016/j.neubiorev.2017.01.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Oliveira AAP, Silva ACCG, Ferreira M Junior. Promoção da Saúde de Doenças na Comunidade, in: Garcia M.L.B. (Ed.), Manual de Saúde da Família. Guanabara Koogan, Rio de Janeiro: 2015; pp.978. [Google Scholar]
  • 38.Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. N. Engl. J. Med. 2020; 383(6):510–512. 10.1056/NEJMp2008017 [DOI] [PubMed] [Google Scholar]
  • 39.Sekowski M, Gambin M, Hansen K, Holas P, Hyniewska S, Pluta A, et al. “Risk of developing posttraumatic stress disorder in COVID-19 survivors: What should mental health specialists prepare for?” PsyArXiv. 2020; 3 10.31234/osf.io/bnkve [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

M Harvey Brenner

27 Nov 2020

PONE-D-20-26835

Exploratory study on the psychological impact of COVID-19 on the general Brazilian population

PLOS ONE

Dear Dr. Serafim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please follow closely suggestions for revisions by reviewers 1 and 2. Reviewer 1 requests more information about the reporting of exclusion criteria as well as on the online questionnaire. Reviewer 1 also recommends upfronting the most relevant study findings at the beginning of the discussion. In addition, please reference the issue of the unique sensory processing patterns in subjects with anxiety and depression and refer to the potential risk of suicide, as discussed by reviewer 1.

Please address the issues reviewer 2 raises with respect to statistical analysis, especially points 3-13. If there were any leaks to the sample, how would the authors repair them. Please also revise your central hypothesis presented at the end of the introduction following reviewer 2' suggestions. Please also address question 2 and check out The Equator Network.

Please submit your revised manuscript by 1/1/2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

M. Harvey Brenner, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

4. Please ensure that you include a title page within your main document. You should list all authors and all affiliations as per our author instructions and clearly indicate the corresponding author.

5.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is, in summary, an interesting paper aimed to explore the prevalence of depression, anxiety, and stress symptoms, and behavioral aspects amidst the COVID-19 pandemic in a Brazilian population. The authors reported that some individuals contracted the virus and had dead friends or relatives. In addition, there was more consumption of drugs, tobacco, medication, and food. Importantly, almost half of participants, especially females, subjects without children, students, patients with chronic diseases, and individuals who had contact with others diagnosed with COVID-19 expressed symptoms of depression, anxiety, and stress.

The authors may find as follows my main comments/suggestions.

First, when within the Introduction section, the authors correctly reported that isolation and quarantine linked to Covid-19 infection are associated with psychological problems such as anxiety, depression, sleep disorders, abstinence, regression, and hallucinations, they could even briefly describe the involvement of sensory perception whch is implicated in emotional processes of individuals with psychological problems. Importantly, the unique sensory processing patterns in subjects psychological problems have been reported. Hyposensitivity or hypersensitivity may be "trait" markers of individuals with anxiety and depression and interventions should refer to the individual unique sensory profiles and their behavioral and functional impact in the context of real life. Thus, given the above information, my suggestion is to include throughout the manuscript, the paper published in 2016 on Psychiatry Res (PMID: 26738981).

In addition, the authors might even report the link between anxiety, depression, and specific adverse clinical outcomes (e.g., suicidal behavior). Importantly, depressed patients may frequenly display affective dysregulated temperaments and suicidal behavior. Overall, more than half of patients with dysregulated temperaments reported higher levels of hopelessness and may be considered at suicide risk. Thus, in order to briefly address the mentioned topics (although i understand that the link between anxiety, depression, and negative outcomes including suicidal behavior) is not the main aim of investigation of the present manuscript, the study below (PMID: 23104655) could be included throughout the main text by the authors.

Moreover, as the most relevant aims/objectives of the present study have been directly reported throughout the Introduction section, the main study hypotheses should be similarly described within the main text.

Furthermore, as inclusion criteria have been well described, exclusion criteria need to be extensively reported.

Furthermore, more information about the online questionnaire comprising 108 questions could be provided for the general readership.

In addition, the authors should immediately present and discuss, in the first lines of the Discussion section, their most relevant study findings. Conversely, they seem to focus with redundance on the main introductive statements as well as upon the main aims/objectives of this paper that should be stressed elsewhere within the main text.

Finally, which type of interventions the authors suggested for subgroups of subjects who were found to be more susceptible to the psychological impact of Covid-19 infection? Here, more details/ information are required to this specific regard.

Reviewer #2: Dears author,

The review of the article allows us to verify the commitment and the accuracy of the authors. So this review is intended to indicate some minor modifications listed below:

1- I suggest the revision of the central hypothesis presented at the end of the introduction. Although the authors compare the findings with other studies, the hypothesis does not highlight the main findings of the present study.

2 - It is unclear whether the authors make use of guidelines for scientific disclosure and transparency. Considering the methodological design and the way that the data were obtained, the use of these guidelines is encouraged (eg CHERRIES, STROBE ...). Therefore, authors can check out The EQUATOR Network.

3 - it is unclear if there were any leaks to the sample.

4 - it is unclear whether there are any missing in the data, and how these were considered for statistical analysis.

5 - I suggest improving the information regarding the socio-demographic questionnaire. With more specificity on questions and answer categories.

6 - It is not clear how the authors made the adaptation of the "Coping Strategy Inventory" and the criteria used by them.

7 - The last paragraph of item 2.1 would be better allocated in item 2.3.

8 - In the ‘data analysis’, it is not clear whether the significance level adopted concerns only chi-square or all statistical test.

9 - It is encouraged to refer to the literature, regarding the parameters adopted for the interpretation of the Rho.

10 - The criteria used for dividing the participants into age groups are not clear.

11- Table 1 reports data that were not used in other statistical analyzes and that contribute little to the discussion of the study. Authors are invited to verify the need for these data in the article.

12 - The inclusion of subtitles in table 2 is suggested, regarding the statistical test used to provide the p value.

13 - In table 3, the mean and standard deviation values were provided. However, considering the non-parametric analyzes, the inclusion of the median, respective CI or Interquartile Range, plus the percentage of the frequency for the chi-square test is suggested.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Feb 3;16(2):e0245868. doi: 10.1371/journal.pone.0245868.r002

Author response to Decision Letter 0


22 Dec 2020

We appreciate the opportunity to review and resubmit our manuscript PONE-D-20-26835 – “Exploratory study on the psychological impact of COVID-19 on the general Brazilian population” in accordance to the reviewers´ suggestions.

In this way, we review the manuscript and respond to all concerns of reviewer 1 and 2. Modifications to the manuscript are highlighted in yellow

Attachment

Submitted filename: PONE-D-20-26835 Response to Reviewers.doc

Decision Letter 1

M Harvey Brenner

11 Jan 2021

Exploratory study on the psychological impact of COVID-19 on the general Brazilian population

PONE-D-20-26835R1

Dear Dr. Serafim,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

M. Harvey Brenner, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In the revised paper, the authors addressed most of the major questions raised by Reviewers improving both the main structure and quality of the present paper. I have no further additional comments.

Reviewer #2: In this review, I was able to verify the attention and care of the authors in answering my previous comments. I don't have new recommendations.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

M Harvey Brenner

13 Jan 2021

PONE-D-20-26835R1

Exploratory study on the psychological impact of COVID-19 on the general Brazilian population

Dear Dr. Serafim:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor M. Harvey Brenner

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (XLS)

    Attachment

    Submitted filename: PONE-D-20-26835 Response to Reviewers.doc

    Data Availability Statement

    The data are fully available and were made available on the submission platform in the topic "Supporting information" with the file "Covid-19 Research Database General Population Brazil".


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES